0.00Open0.00Pre Close0 Volume0 Open Interest1.50Strike Price0.00Turnover0.00%IV500.00%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma5.02Leverage Ratio--Theta--Rho--Eff Leverage--Vega
GlycoMimetics Stock Discussion
GlycoMimetics Inc - on Dec 19, Nasdaq Grants GlycoMimetics 180 Days to Regain Compliance
what is behind it?
still have eyes on this
GlycoMimetics | SC 13G: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(9.9%),Peter Kolchinsky(9.9%), etc.
No comment yet